Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

β-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure.

Skowera A, Ladell K, McLaren JE, Dolton G, Matthews KK, Gostick E, Kronenberg-Versteeg D, Eichmann M, Knight RR, Heck S, Powrie J, Bingley PJ, Dayan CM, Miles JJ, Sewell AK, Price DA, Peakman M.

Diabetes. 2015 Mar;64(3):916-925. doi: 10.2337/db14-0332. Epub 2014 Sep 23.

2.

A distinct immunogenic region of glutamic acid decarboxylase 65 is naturally processed and presented by human islet cells to cytotoxic CD8 T cells.

Knight RR, Dolton G, Kronenberg-Versteeg D, Eichmann M, Zhao M, Huang GC, Beck K, Cole DK, Sewell AK, Skowera A, Peakman M.

Clin Exp Immunol. 2015 Jan;179(1):100-7. doi: 10.1111/cei.12436.

3.

Clinical-grade multipotent adult progenitor cells durably control pathogenic T cell responses in human models of transplantation and autoimmunity.

Reading JL, Yang JH, Sabbah S, Skowera A, Knight RR, Pinxteren J, Vaes B, Allsopp T, Ting AE, Busch S, Raber A, Deans R, Tree TI.

J Immunol. 2013 May 1;190(9):4542-52. doi: 10.4049/jimmunol.1202710. Epub 2013 Apr 1.

4.

Human β-cell killing by autoreactive preproinsulin-specific CD8 T cells is predominantly granule-mediated with the potency dependent upon T-cell receptor avidity.

Knight RR, Kronenberg D, Zhao M, Huang GC, Eichmann M, Bulek A, Wooldridge L, Cole DK, Sewell AK, Peakman M, Skowera A.

Diabetes. 2013 Jan;62(1):205-13. doi: 10.2337/db12-0315. Epub 2012 Aug 30.

5.

Circulating preproinsulin signal peptide-specific CD8 T cells restricted by the susceptibility molecule HLA-A24 are expanded at onset of type 1 diabetes and kill β-cells.

Kronenberg D, Knight RR, Estorninho M, Ellis RJ, Kester MG, de Ru A, Eichmann M, Huang GC, Powrie J, Dayan CM, Skowera A, van Veelen PA, Peakman M.

Diabetes. 2012 Jul;61(7):1752-9. doi: 10.2337/db11-1520. Epub 2012 Apr 20.

6.

Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.

Bulek AM, Cole DK, Skowera A, Dolton G, Gras S, Madura F, Fuller A, Miles JJ, Gostick E, Price DA, Drijfhout JW, Knight RR, Huang GC, Lissin N, Molloy PE, Wooldridge L, Jakobsen BK, Rossjohn J, Peakman M, Rizkallah PJ, Sewell AK.

Nat Immunol. 2012 Jan 15;13(3):283-9. doi: 10.1038/ni.2206.

7.

Contributions of anterior and posterior association cortex to the human somatosensory P3.

Yamaguchi S, Knight RR.

Electroencephalogr Clin Neurophysiol Suppl. 1995;44:130-9. No abstract available.

PMID:
7649014
8.

A study of reproduction, disease and physiological blood and serum values in Idaho elk.

Vaughn HW, Knight RR, Frank FW.

J Wildl Dis. 1973 Oct;9(4):296-301. No abstract available.

PMID:
4361504
9.

Biotelemetry applied to elk management.

Knight RR, McLean LS, McNeill GR.

Biomed Sci Instrum. 1972 May;9:171-5. No abstract available.

PMID:
5029007
10.

The preparation and properties of horse antihuman lymphocyte serum and globulin.

Woiwod AJ, Courtenay JS, Edwards DC, Epps HB, Knight RR, Mosedale B, Phillips AW, Rahr L, Thomas D, Woodrooffe JG, Zola H.

Transplantation. 1970 Aug;10(2):173-86. No abstract available.

PMID:
4988767

Supplemental Content

Loading ...
Support Center